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Abstract
Background: Hyperventilation-induced hypocapnia (HV) reduces elevated intracranial pressure (ICP), a dangerous
and potentially fatal complication of traumatic brain injury (TBI). HV decreases the arteriolar diameter of intracranial
vessels, raising the risk of cerebral ischemia. The aim of this study was to characterize the effects of moderate short-
term HV in patients with severe TBI by using concomitant monitoring of cerebral metabolism, brain tissue oxygen
tension (PbrO2), and cerebral hemodynamics with transcranial color-coded duplex sonography (TCCD).
Methods: This prospective trial was conducted between May 2014 and May 2017 in the surgical intensive care unit
(ICU) at the University Hospital of Zurich. Patients with nonpenetrating TBI older than 18 years of age with a
Glasgow Coma Scale (GCS) score < 9 at presentation and with ICP monitoring, PbrO2, and/or microdialysis (MD)
probes during ICU admission within 36 h after injury were included in our study. Data collection and TCCD
measurements were performed at baseline (A), at the beginning of moderate HV (C), after 50 min of moderate HV
(D), and after return to baseline (E). Moderate HV was defined as arterial partial pressure of carbon dioxide 4–4.7 kPa.
Repeated measures analysis of variance was used to compare variables at the different time points, followed by
post hoc analysis with Bonferroni adjustment as appropriate.
Results: Eleven patients (64% males, mean age 36 ± 14 years) with an initial median GCS score of 7 (IQR 3–8) were
enrolled. During HV, ICP and mean flow velocity (CBFV) in the middle cerebral artery decreased significantly.
Glucose, lactate, and pyruvate in the brain extracellular fluid did not change significantly, whereas PbrO2 showed a
statistically significant reduction but remained within the normal range.
Conclusion: Moderate short-term hyperventilation has a potent effect on the cerebral blood flow, as shown by
TCCD, with a concomitant ICP reduction. Under the specific conditions of this study, this degree of hyperventilation
did not induce pathological alterations of brain metabolites and oxygenation.
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Introduction
Hyperventilation-induced arterial hypocapnia (HV) has
been used for decades in neuroanesthesia and neuroin-
tensive care, especially in the management of patients
with severe traumatic brain injury (TBI) and concomi-
tant elevated intracranial pressure (ICP). Increased al-
veolar ventilation induces a dose-response decrease in
arterial partial pressure of carbon dioxide (PaCO2), caus-
ing a parallel reduction of carbon dioxide partial pres-
sure in the extracellular brain compartment with tissue
alkalosis. This results in vasoconstriction of the cerebral
arterioles [1, 2]. Consequently, cerebral blood flow
(CBF), cerebral blood volume (CBV), and ultimately ICP
decrease.
The most relevant criticism of the use of HV is the
risk of cerebral ischemia and hypoxia, especially in the
acute phase of TBI [3]. This risk has been documented
in several studies [4, 5], but the net effects of HV on re-
gional CBF and metabolism are still debated [6].
Despite those concerns, HV is still widely used, even
in the absence of elevated ICP and without brain oxy-
genation monitoring [7]. However, there is an inter-
national consensus that HV could have deleterious
effects, especially by reducing CBF and brain oxygen-
ation. To minimize this risk, HV should be used only to
counteract the raised ICP, rather than prophylactically,
and only with appropriate monitoring of CBF and/or
oxygenation [8–11]. While continuous global measure-
ments of CBF are not feasible at the bedside, cerebral
blood flow velocity in the middle cerebral artery (CBFV)
may be measured by transcranial Doppler and has been
used to monitor the effects of hypocapnia [12, 13]. The
present study was conducted to quantify potential ad-
verse effects of moderate short-term HV during the
acute phase of severe TBI on cerebral hemodynamics,
oxygenation, and metabolism.
Methods
The Institutional Ethics Committee of Zurich approved
the research protocol of this prospective clinical trial
(KEK-ZH 2012-0542). Informed consent was obtained
from the patients’ next of kin prior to study enrollment
and/or from the patients after ICU discharge.
Patient population and initial stabilization
Inclusion criteria involved patients (≥ 18 years of age) with
nonpenetrating head injury, with initial GCS score < 9 prior
to sedation and intubation, extended neuromonitoring with
ICP, PbrO2, and/or microdialysis probes, undergoing inva-
sive mechanical ventilation with fraction of inspired oxy-
gen < 60% and positive end-expiratory pressure < 15
cmH2O. Exclusion criteria were decompressive craniect-
omy, pregnancy, preexisting neurologic disease, previous
TBI, acute cardiovascular disease, severe respiratory failure,
acute or chronic liver disease, sepsis, and failure to obtain
satisfactory bilateral TCCD signals. Patients with persisting
hypovolemia or hemodynamic instability despite previous
fluid resuscitation (defined as global end-diastolic volume
index < 680ml/m2, central venous oxygen saturation
[ScvO2] < 60%, or increase in mean arterial blood pressure
[MAP] > 15% after passive leg raise test) were excluded. All
patients were treated according to a cerebral perfusion ori-
entated protocol aiming to achieve cerebral perfusion pres-
sure (CPP) > 70mmHg, ICP ≤ 20mmHg, and PbrO2 > 15
mmHg. PaCO2 was targeted at 4.8–5.2 kPa.
Monitoring
MAP, ICP, CPP, arterial oxygen saturation (SaO2),
end-tidal CO2 (etCO2), and PbrO2 were continuously
monitored. ICP was measured with a fiberoptic device
(Camino, San Diego, CA, USA) and PbrO2 with a
Clark-type microcatheter (Licox GmbH, Kiel, Germany).
Cerebral microdialysis (MD) was performed using a
catheter (CMA70; Microdialysis, Solna, Sweden) with a
membrane length of 10 mm and a molecular mass cutoff
of 20 kDa, which was perfused by a microinjection pump
(CMA 106; Microdialysis) with artificial cerebrospinal
fluid at a flow rate of 0.3 μl/min. Samples were collected
every hour and immediately analyzed for glucose, lactate,
and pyruvate with a bedside MD analyzer (CMA 600;
CMA/Microdialysis). Sampling was performed at 1-h in-
tervals in order to allow the detection of sufficient con-
centration of analytes in the microdialysate. ICP, PbrO2,
and MD catheters were placed in the white frontal mat-
ter, usually on the side of the brain with more significant
injury. The correct position of the catheters was con-
firmed by computed tomography.
TCCD examinations of the middle cerebral artery
(MCA) were performed bilaterally through the transtem-
poral acoustic window by two experienced physicians
(SK, GB) according to standard techniques [14, 15] using
a 2-MHz Probe (Philips CX 50; Philips Healthcare, An-
dover, MA, USA). Three repeated measurements of the
peak systolic velocity (PSV) and end-diastolic velocity
(EDV) were performed for each side. The device auto-
matically calculated CBFV and pulsatility index (PI). PI
was chosen for its high predictive value in case of in-
creased ICP and low CPP [16].
Study protocol
Patients were enrolled in the study within 36 h of sus-
taining trauma. Under baseline conditions, a TCCD
examination was performed, and all parameters were re-
corded (Fig. 1, point A). The alveolar ventilation was
then increased over a 10-min period to obtain moderate
HV by a stepwise increase in tidal volume and respira-
tory rate until a reduction of etCO2 of 0.7 kPa (Fig. 1,
point B) was achieved.
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After 10 min of stable etCO2, a second TCCD meas-
urement was made (beginning of HV; Fig. 1, point C).
The etCO2 value was kept stable for 40 min, followed by
a third TCCD examination (Fig. 1, point D). Finally, nor-
moventilation was reestablished over 10 min, and all var-
iables were allowed to return to baseline (Fig. 1, point
E). A final TCCD examination was conducted at this
time point. At each time point, MAP, ICP, CPP, PbrO2,
SpO2, and etCO2 were recorded.
Microdialysate samples for glucose, lactate, and pyru-
vate concentrations were collected 1 h before A (A − 1
h) as a baseline measurement and 1 h (D + 1 h) and 2 h
(D + 2 h) after D to detect possible changes induced by
moderate HV. Arterial blood gas tests (ABG) were ob-
tained at points A, C, D, and E to monitor the changes
of pH and PaCO2.
Statistical analysis
Data were analyzed to produce mean ± SD or median with
IQR, unless otherwise indicated. Repeated-measures ana-
lysis of variance (ANOVA) was used to compare all vari-
ables. When the F-ratio of the ANOVA reached a critical
level (corresponding to p < 0.05), post hoc analysis with
Bonferroni adjustment was used. All tests were performed
two-sided, and p < 0.05 was considered statistically signifi-
cant. Statistical analysis was performed using Stata version
12.1 software (StataCorp LP, College Station, TX, USA).
Results
Demographic data
During the study period, 628 patients with TBI were ad-
mitted to the surgical ICU. A breakdown of reasons for
exclusion is presented in Fig. 2. Eleven patients with se-
vere TBI were included; 64% were males, with a mean
age of 36 ± 14 years. The median first GCS score was 7
(IQR 3–8). The admission computed tomographic (CT)
scan identified several brain lesions, very often combined.
An epidural hematoma was diagnosed in three patients
(27%), a subdural hematoma in seven (64%), contusions in
eight (73%), and edema/swelling in three (27%).
On average, the Injury Severity Score (ISS) was 31 ±
11, and the Simplified Acute Physiology Score (SAPS) II
24 h after TBI was, on average, 48 ± 9. The study was
performed, on average, 23 h after TBI.
Ventilation parameters
Changes in PaCO2 during the test and other respiratory
variables are shown in Table 1.
Effects of hyperventilation on systemic and cerebral
hemodynamics
MAP and HR (Table 2) did not change significantly
during the study. Mean ICP was 16 ± 6mmHg (A),
decreased significantly to 8 ± 6mmHg (p < 0.0001)
during C, and remained stable during D (10 ± 7mmHg;
p = 0.30). On return to normoventilation (E), ICP
increased significantly to 14 ± 6mmHg (p = 0.003 com-
pared with D) and was similar to A (p = 0.06).
Effects of hyperventilation on mean flow velocity and PI
in the middle cerebral artery
TCCD measurements in the right and left MCAs were an-
alyzed separately. CBFV was 81 ± 23 cm/s and 80 ± 22 in
the right and left MCAs, respectively. During C, CBFV de-
creased to 69 ± 21 cm/s in the right MCA (p = 0.0002) and
to 66 ± 17 cm/s in the left MCA (p = 0.006). CBFV did not
change significantly during D (71 ± 20 cm/s, p = 0.38, and
63 ± 15 cm/s, p = 0.48, in the right and left MCA, respect-
ively) compared with C. During E, CBFV was 77 ± 28 cm/
s (p = 0.21, compared with D) and 75 ± 24 cm/s (p = 0.005,
compared with D) at the right and left sides, respectively.
A B C D E
Fig. 1 Study protocol. At different time points, several variables were collected and transcranial color-coded duplex sonography (TCCD)
measurements were performed. A = Baseline. B = Increasing minute ventilation. C = Begin moderate hyperventilation with target PaCO2 4–4.7
kPa. D = After moderate hyperventilation for 50 min. E = Return to baseline. Glucose, lactate, and pyruvate concentrations in the extracellular
fluid were sampled by microdialysis 1 h before A (A − 1 h) and 1 h (D + 1 h) and 2 h after D (D + 2). etCO2 End-tidal CO2 (kPa), MV Minute
ventilation (L/min), HR Heart rate (beats/min), MAP Mean arterial pressure (mmHg), ICP Intracranial pressure (mmHg), CPP Cerebral perfusion
pressure (mmHg), PbrO2 Brain tissue oxygen tension (mmHg), ABGA Arterial blood gas analysis
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PI was 1.03 ± 0.17 and 0.96 ± 0.15 in the right and left
MCAs, respectively. During the study, PI did not change
significantly in the right MCA (Table 3). In the left
MCA, PI remained stable during C (1.06 ± 0.10, p =
0.056, compared with A), increased significantly during
D (1.07 ± 0.14, p < 0.03, compared with A), and remained
stable during E (1.02 ± 0.14, p = 0.12, compared with D).
Changes of PSV and EDV on both sides are shown in
Table 3.
Brain tissue oxygen tension and cerebral metabolism
PbrO2 and MD were measured in 10 and 9 patients,
respectively. Eight patients got PbrO2 and MD
simultaneously, and both probes were placed close to
each other. The parenchyma surrounding the probes ap-
peared normal on the CT scan in nine patients, seven of
them with both PbrO2 and MD monitoring, one with
only MD monitoring, and one with only PbrO2. In two
cases, the parenchyma surrounding the probes appeared
pathological; one of them had PbrO2 and MD probes
inserted, and one only a PbrO2 probe.
Mean PbrO2 was 32 ± 10 mmHg; it remained
stable during C (33 ± 10 p = 0.50), decreased during
D (30 ± 8 p = 0.003, compared with C), and
remained stable during E (30 ± 8 p = 0.90 compared
with D) (Table 2).
Table 1 Respiratory variables
n = 11 A
Baseline
B
Minute ventilation
C
Moderate hyperventilation
D
50 min of moderate hyperventilation
E
Return to baseline
etCO2 (kPa) 5.0 (0.7) 4.3 (0.6)* 4.2 (0.6)*
§ 4.0 (0.7)*§ 4.7 (0.7)*§¶Ŧ
MV (L/min) 6.9 (1.4) 8.6 (1.6)* 8.7 (1.7)* 8.4 (1.5)* 6.8 (1.4)§¶Ŧ
pH 7.37 (0.09) 7.45 (0.02)* 7.46 (0.03)*¶ 7.41 (0.03)¶Ŧ
PaCO2 (kPa) 5.0 (0.2) 4.3 (0.2)* 4.1 (0.4)*
¶ 4.7 (0.4)*¶Ŧ
PaO2 (kPa) 17.2 (1.5) 17.9 (1.9) 18.8 (2.3)*
¶ 17.4 (1.2)Ŧ
Abbreviations: A Baseline, B Increasing minute ventilation, C Begin moderate hyperventilation with target PaCO2 4–4.7 kPa, D After moderate hyperventilation for
50 min, E Return to baseline, etCO2 End-tidal CO2, MV Minute ventilation (L/min), PaCO2 Partial pressure arterial carbon dioxide (kPa), PaO2 Partial pressure arterial
oxygen (kPa)
Data are expressed as mean (SD)
* p < 0.05 compared with A
§ p < 0.05 compared with B
¶ p < 0.05 compared with C
Ŧ p < 0.05 compared with D
Fig. 2 Flowchart of the study. During the study period, 627 patients were admitted with a diagnosis of traumatic brain injury (TBI). Reasons for
exclusion from the study are shown on the right side of the chart. ICU Intensive care unit, ICP intracranial pressure, GCS Glasgow Coma Scale,
PbrO2 Brain tissue oxygen tension, MD Cerebral microdialysis
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The mean extracellular fluid concentrations of glucose,
lactate, pyruvate, and the lactate/pyruvate ratio in the
brain 1 h before and 1 and 2 h after moderate HV are
reported in Table 4. No significant changes were
observed.
Discussion
Main findings
The aim of this study was to detect possible adverse ef-
fects of moderate HV in patients with severe TBI during
the acute phase postinjury. To our knowledge, this is the
first study using a multimodal monitoring set (MD,
PbrO2, and TCCD, together with ICP and CPP) to inves-
tigate this.
Our data suggest that moderate short-term HV was ef-
fective in lowering ICP with a remarkable effect on CBF
velocities, as shown by the reduction of the CBFV in the
MCAs bilaterally and by a slight increase in PI. The
CBFV in the MCAs in the study population at baseline
was normal, suggesting a physiological global CBF. In
the course of moderate HV, CBFV and hence CBF de-
creased significantly, as in previous studies [17, 18].
These findings are consistent with vasoconstriction in
the brain vasculature leading to a reduction in CBF and
likely in CBV.
MAP and HR remained stable during moderate HV, as
demonstrated by Minhas et al. [13] in volunteers. However,
in patients receiving positive pressure ventilation, sedation,
and hypovolemia, the interactions between hypocapnia and
hemodynamics are more complex [2]. Due to the possible
systemic effects of hypocapnia, patients with persisting
hypovolemia or hemodynamic instability despite previous
fluid resuscitation were excluded.
Our work included two additional variables, PbrO2
and MD, with the specific aim of demonstrating possible
tissue hypoxia and/or disturbed metabolic patterns.
On the basis of our results, there was a PbrO2 re-
duction, but within a physiological range. Addition-
ally, MD with a stable Lactate/pyruvate (L/P) ratio
was not indicative of an energy crisis.
Table 2 Systemic and cerebral hemodynamics
n = 11 A
Baseline
B
Minute
ventilation
C
Moderate hyperventilation
D
50 min of moderate hyperventilation
E
Return to baseline
HR (beats/min) 72 (16) 72 (17) 71 (17) 71 (17) 66 (16)
MAP (mmHg) 92 (10) 92 (10) 93 (12) 90 (10) 94 (13)
ICP (mmHg) 16 (6) 8 (5)* 8 (6)* 10 (7)* 14 (6)§¶Ŧ
CPP (mmHg) 77 (9) 84 (9)* 85 (10)* 81 (14) 80 (11)§¶
PbrO2 (mmHg) 32 (10) 33 (9) 33 (10) 30 (8)
§¶ 30 (8)§
Abbreviations: A Baseline, B Increasing minute ventilation, C Begin moderate hyperventilation with target PaCO2 4–4.7 kPa, D After moderate hyperventilation for
50 min, E Return to baseline, HR Heart rate (beats/min), MAP Mean arterial pressure (mmHg), ICP Intracranial pressure (mmHg), CPP Cerebral perfusion pressure
(mmHg), PbrO2 Brain tissue oxygen tension (mmHg)
N = 11 patients; + = 10 patients. Data are expressed as mean (SD)
* p < 0.05 compared with A
§ p < 0.05 compared with B
¶ p < 0.05 compared with C
Ŧ p < 0.05 compared with D
Table 3 Transcranial color-coded duplex sonography variables measured in middle cerebral arteries bilaterally
n = 11 A
Baseline
C
Moderate hyperventilation
D
50 min of moderate hyperventilation
E
Return to baseline
CBFV right (cm/s) 81 (23) 69 (21)* 71 (20)* 77 (28)
CBFV left (cm/s) 80 (22) 66 (17)* 63 (15)* 75 (24)¶Ŧ
PSV right (cm/s) 136 (37) 117 (34)* 120 (33)* 129 (42)
PSV left (cm/s) 131 (35) 110 (25)* 107 (24)* 126 (37)¶Ŧ
EDV right (cm/s) 56 (20) 45 (16)* 46 (16)* 51 (22)¶
EDV left (cm/s) 54 (16) 43 (13)* 41 (11)* 52 (17)¶Ŧ
PI right 1.03 (0.17) 1.08 (0.16) 1.05 (0.23) 1.05 (0.17)
PI left 0.96 (0.15) 1.06 (0.10) 1.07 (0.14)* 1.02 (0.14)
Abbreviations: A Baseline, B Increasing minute ventilation, C Begin moderate hyperventilation with target PaCO2 4–4.7 kPa, D After moderate hyperventilation for
50 min, E Return to baseline. CBFV Mean flow velocity of the middle cerebral artery (cm/s), PSV Peak systolic velocity (cm/s), EDV End-diastolic velocity (cm/s), PI
Pulsatility index
* p < 0.05 compared with A
¶ p < 0.05 compared with C
Ŧ p < 0.05 compared with D
N = 11 patients, + = 10 patients. Data are expressed as mean (SD)
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What is already known
In the last 30 years, HV has been fiercely debated. After
initial widespread use [19], the effects of HV on out-
come were questioned in a randomized study [20]. That
study included a total of 113 patients in 3 groups and
used different levels of HV in all arms. ICP was kept
stable in all groups. At 3 and 6months after injury, pa-
tients with a motor score of 4–5 in the hyperventilation
group had less favorable outcomes than the other
groups. However, the control group was hyperventilated
and had a PaCO2 of 31–32 mmHg for the first 5 study
days. Additionally, HV was induced prophylactically, re-
gardless of ICP.
More accurate studies of pathophysiological changes
induced by HV have been performed by two authorita-
tive groups. Coles et al. measured a significant reduction
of CBF with PET scans and an increase in the volume of
severely hypoperfused tissue following HV [4] with a
PaCO2 reduction from 4.8 to 3.9 kPa. Diringer et al., on
the contrary, using an analogous PET technique, did not
disclose any alteration of oxygen metabolism in two
groups of patients with TBI managed with different de-
grees of HV [17]. They concluded that oxygen metabol-
ism was maintained due to the low baseline metabolic
rate and compensatory increase in oxygen extraction
fraction.
How our data compare with the literature: limitations
Our data questioned if HV, even when effective in redu-
cing CBF and ICP, induced measurable changes compat-
ible with true ischemia (defined as a CBF insufficient for
preserving adequate tissue oxygenation and metabolism).
For a fair comparison with the existing evidence, how-
ever, the study limitations should be acknowledged. First,
the small sample size limits the generalizability of the
findings. More accurate analyses, for instance looking at
sex differences in vasoreactivity or association between
PI and outcome, were clearly not feasible [21, 22]. Sec-
ond, we decided to perform only a moderate degree of
short-term HV. This choice was dictated by two con-
cerns: the risk of ischemia and the time frame of the test.
We were aware that the brain is especially vulnerable to
ischemia during the acute phase after trauma [23]. It
may well be that we did not detect pathological changes
because of the mild level of hypocapnia used for a short
time interval. Third, the MD and PbrO2 probes explore
only small areas of the brain; therefore, we cannot ex-
clude concomitant changes in other brain regions [24,
25].
In our study population, however, the MD and the
PbrO2 probes were placed, in the majority of the cases,
in the most injured hemisphere of the brain. Interest-
ingly, the cerebral glucose at baseline was normal,
whereas the L/P ratio at baseline was markedly increased
and pathological [26], reflecting tissue injury despite
“normal” parenchyma on the CT scan. From this point
of view, we were exploring a vulnerable portion of the
brain, where potential side effects of HV would have
been more likely to be detected. Furthermore, because
none of the probes were placed directly in the site of
contusion and only two were in pericontusional tissue,
the effect of HV on PbrO2 should not have been com-
promised [24].
Conclusions
Our findings add evidence to the belief that a moderate
degree of short-term HV is effective in reducing ICP
through CBFV modifications as an estimation of CBF.
Furthermore, a moderate degree of HV reduces PbrO2,
but within a physiological range, and does not signifi-
cantly change the cerebral energy metabolism. Further
investigations of prolonged and more severe HV, in the
context of intracranial hypertension and in a larger study
population, are needed to characterize the risks and ben-
efits of HV in severe TBI.
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